Page last updated: 2024-08-25

beta-hydroxyisovaleric acid and Critical Illness

beta-hydroxyisovaleric acid has been researched along with Critical Illness in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Alquati, O; Balzarini, A; Caccialanza, R; Cereda, E; Cerri, M; Cozzi, S; Crotti, S; Grasselli, G; Guzzardella, A; Masi, S; Pennacchio, N; Piano, M; Resta, MV; Ripamonti, C; Tamayo, L; Tavola, M; Vadalà, R1
Bagnoud, G; Becce, F; Berger, MM; Deutz, NEP; Engelen, MPKJ; Pantet, O; Schmidt, S; Ten Have, GAM; Thaden, JJ; Viana, MV; Voidey, A1
Callahan, LA; Netzel, PF; Schroder, EA; Supinski, GS; Wang, L; Westgate, PM1
Hashimoto, H; Kanda, N; Kihata, A; Morimura, N; Nakamura, K; Naraba, H; Sonoo, T; Takahashi, Y1
Brett, SJ; Frost, G; Hickson, M; Wandrag, L1

Reviews

1 review(s) available for beta-hydroxyisovaleric acid and Critical Illness

ArticleYear
Impact of supplementation with amino acids or their metabolites on muscle wasting in patients with critical illness or other muscle wasting illness: a systematic review.
    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, 2015, Volume: 28, Issue:4

    Topics: Aged; Amino Acids; Amino Acids, Essential; Body Composition; Creatine; Critical Illness; Diet; Dietary Supplements; Enteral Nutrition; Female; Humans; Intensive Care Units; Leucine; Male; MEDLINE; Muscular Atrophy; Nutritional Status; Valerates

2015

Trials

3 trial(s) available for beta-hydroxyisovaleric acid and Critical Illness

ArticleYear
Impact of β-hydroxy-β-methylbutyrate (HMB) on muscle loss and protein metabolism in critically ill patients: A RCT.
    Clinical nutrition (Edinburgh, Scotland), 2021, Volume: 40, Issue:8

    Topics: Aged; Amino Acids; Body Composition; Critical Illness; Dietary Supplements; Double-Blind Method; Electric Impedance; Enteral Nutrition; Female; Humans; Intensive Care Units; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Organ Dysfunction Scores; Prospective Studies; Quadriceps Muscle; Ultrasonography; Valerates

2021
A randomized controlled trial to determine whether beta-hydroxy-beta-methylbutyrate and/or eicosapentaenoic acid improves diaphragm and quadriceps strength in critically Ill mechanically ventilated patients.
    Critical care (London, England), 2021, 08-26, Volume: 25, Issue:1

    Topics: Aged; Critical Illness; Diaphragm; Eicosapentaenoic Acid; Female; Humans; Kentucky; Male; Middle Aged; Muscle Strength; Quadriceps Muscle; Respiration, Artificial; Valerates

2021
β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine Complex on Muscle Volume Loss in Critically Ill Patients: A Randomized Control Trial.
    JPEN. Journal of parenteral and enteral nutrition, 2020, Volume: 44, Issue:2

    Topics: Arginine; Critical Illness; Dietary Supplements; Glutamine; Humans; Muscle, Skeletal; Nutritional Support; Prospective Studies; Valerates

2020

Other Studies

1 other study(ies) available for beta-hydroxyisovaleric acid and Critical Illness

ArticleYear
Potential benefits of using an energy-dense, high-protein formula enriched with β-hydroxy-β-methylbutyrate, fructo-oligosaccharide, and vitamin D for enteral feeding in the ICU: A pilot case-control study in COVID-19 patients.
    Nutrition (Burbank, Los Angeles County, Calif.), 2023, Volume: 106

    Topics: Case-Control Studies; COVID-19; Critical Illness; Energy Intake; Enteral Nutrition; Humans; Intensive Care Units; Oligosaccharides; Proteins; Respiration, Artificial; Vitamin D

2023